Latest News

  • REGULATORY

    14 Aug 2025

    Can the FDA’s PreCheck End Costly Drug Launch Delays?
  • PARTNERSHIPS

    7 Aug 2025

    From Barcelona to Chicago: Esteve Targets U.S. Drugmakers
  • MARKET TRENDS

    1 Aug 2025

    The Biosimilar Boom That’s Rewriting U.S. Pharma
  • TECHNOLOGY

    25 Jul 2025

    AI Supercharges Fermentation: TAPI Boosts Output and Cuts Emissions

The Enzyme Play That Could Rewrite RNA Manufacturing

The Enzyme Play That Could Rewrite RNA Manufacturing

INSIGHTS

29 Jun 2025

New data shows Codexis’ enzyme-based process scaling RNA drug manufacturing with cleaner, faster results.

Can the FDA’s PreCheck End Costly Drug Launch Delays?

REGULATORY

14 Aug 2025

Can the FDA’s PreCheck End Costly Drug Launch Delays?

FDA’s PreCheck pilot accelerates drug plant reviews, boosting US biologics production and cutting costly launch delays.

From Barcelona to Chicago: Esteve Targets U.S. Drugmakers

PARTNERSHIPS

7 Aug 2025

From Barcelona to Chicago: Esteve Targets U.S. Drugmakers

Esteve acquires Regis to bring European CDMO expertise to US soil, boosting domestic drug ingredient development and manufacturing service...

The Biosimilar Boom That’s Rewriting U.S. Pharma

MARKET TRENDS

1 Aug 2025

The Biosimilar Boom That’s Rewriting U.S. Pharma

US payers drive biosimilar boom, pressuring fermentation drug makers to cut costs and boost domestic capacity.

AI Supercharges Fermentation: TAPI Boosts Output and Cuts Emissions

TECHNOLOGY

25 Jul 2025

AI Supercharges Fermentation: TAPI Boosts Output and Cuts Emissions

TAPI's AI-driven feed system lifts drug productivity by over 15% while shrinking its carbon footprint.

The Enzyme Play That Could Rewrite RNA Manufacturing

INSIGHTS

29 Jun 2025

The Enzyme Play That Could Rewrite RNA Manufacturing

New data shows Codexis’ enzyme-based process scaling RNA drug manufacturing with cleaner, faster results.

Biotech Duo Rewrites the Rules for Biologic Drug Delivery

PARTNERSHIPS

12 Jun 2025

Biotech Duo Rewrites the Rules for Biologic Drug Delivery

Axio and Likarda unite to fast-track biologic drugs by fusing delivery tech with AI-powered protein manufacturing.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.